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ABSTRACT  
Objective: Novel aroylhydrazone schiff bases were synthesized and were screened for their biological activities.  
Methods: Using HCl as a catalyst, all the compounds were synthesized at room temperature and were characterized by IR and NMR techniques. The 
synthesized Schiff bases were screened for antibacterial, antifungal activities. In silico molecular docking, method was performed to study their anti-
tuberculosis activity against enoyl acyl carrier protein reductase (InhA) from Mycobacterium tuberculosis (PDB id: 2NSD).  
Results: Compound P1 showed good antibacterial activity against gram positive (S. aureus) and gram negative (E. coli) bacterial strains and 
compound J1 showed good antifungal activity against A. niger. Molecular docking results reveal that compound B1 made two numbers of 
electrostatic interactions with 2NSD with more negative C docker interaction value. This indicated that the compound B1 was more active with 
minimum binding potential which is comparable with that of standard compound isoniazid. 
Conclusion: Aroylhydrazones having good biologically activities compared to that of standards were prepared.  
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Tuberculosis (TB) “19th-century illness” could be a high 
communicable killer disease. In 2014, 9.6 million individuals fell sick 
with TB and 1.5 million died from the malady. Over ninety-fifth of TB 
deaths occur in low and middle-income countries, and it's among the 
highest five causes of death for women aged fifteen to forty-four. TB 
could be a leading killer of HIV-positive people: in 2015, one in three 
HIV deaths was because of TB. Globally in 2014, associate calculable 
480000 individuals developed multidrug-resistant TB (MDR-TB). TB 
epidemic by 2030 is among the health targets of the recently 
adopted sustainable development goals [1].  
Therefore, there's associate pressing got to develop new medicine 
against this world’s most difficult public ill health. Drug discovery 
and development could be a complicated, time intense and a rich 
method [2]. It becomes still more expensive when the safety, efficacy 
and other issues are raised. In silico drug design, computational 
approach plays a significant role in all stages of drug development 
from the initial lead design to final stage clinical development [3]. 
Keeping the various biological applications of hydrazones in mind 
and in continuation of our earlier research [13], in the present study 
we reported novel biologically active hydrazone shiff bases using 
2,4,5-trifluorobenzaldehyde as a source of the carbonyl compound. 
The novelty of the present work resided in it’s synthesize and 
molecular docking analysis. Drug discovery and development is a 
complex, lengthy and costly process, entrenched with a high degree 
of uncertainty that a drug will actually succeed. It becomes still more 
expensive when the safety, efficacy and other issues are raised. For 
faster development, nowadays almost every multi-national drug 
company and Contract Research Organization (CRO) involved in 
drug discovery has adopted computational methodology in different 
stages of the design process.  
Many computational methods complement one another and may be 
combined to help rationalize the drug discovery process [14]. In this 
research, we attempted to find the anti-tubercular nature of 
synthesized compounds by virtual screening method. Virtual 
screening uses computational docking method and is used to predict 
the binding position and orientation of small molecules with active 
sites of pathogens. The crystal structure of pathogen available in 
Protein Data Bank could be used for docking studies.  
Docking software is a valuable tool in pharmacy and medicine as 
most drugs are small molecules designed to interact with 
biologically relevant target proteins (receptors) in order to act on 
the biological pathway they are involved in.  
The full therapeutic possibilities of hydrazides were realized after the 
discovery of isonicotinic acid hydrazide (INH) drugs which are in 
clinical practice for more than 50 y [4]. Due to the presence of 
azomethine group (>C=N-NH-CO) hydrazones are considered as a 
special group of compounds and their industrial applications are vast 
[5]. Hydrazones are used as antimicrobial, antioxidant, anti-
tuberculosis, anticancer, antimalarial anti-inflammatory, 
antiplatelet diseases due to their interesting chemical and 
structural properties [6-12]. 
MATERIALS AND METHODS  
All anhydrous solvents and reagents of AR grade were obtained 
from commercial suppliers and used without any further 
purification unless otherwise noted. All the reactions were carried 
out at room temperature. Melting points were determined by open 
capillary and are uncorrected. FT-IR spectral measurements were 
recorded using Perkin Elmer Spectrum-1 FT-IR spectrometer in 
4000-400 cm-1. NMR was recorded with Bruker NMR spectrometers 
operating at 400 MHz for 1H and 100 MHz for 13CNMR. DMSO-d6
To the ethanolic solution of benzo hydrazide (0.1 mol), 2,4,5-
trifluorobenzaldehyde (0.1 mol) and few drops of con HCl were 
added. The reaction mixture was stirred well at room temperature 
for 30 min. Insoluble solid gradually generated was filtered and 
washed with petroleum ether(40-60%) and dried in vacuum 
desicator. The crude solid was recrystallised from absolute ethanol. 
Similar reaction and purification procedures were applied to 
prepare all the compounds. 
 was 
used as a solvent and TMS as an internal reference.  
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Scheme 1: General procedure for the synthesis of aroylhydrazone schiff bases 
 
Determination of antimicrobial activity 
The antimicrobial activities of synthesized compounds were 
screened against gram-positive bacteria ( Staphylococcus aureus), 
gram-negative (Escherichia coli) and fungi (Aspergillus niger) strains 
by agar well diffusion method [15] at a concentration level of 
100μg/ml. The microorganisms used were obtained, identified and 
confirmed by Microbiologists, Department of Microbiology, 
Thanjavur Medical College, Thanjavur. Nutrient agar was used as 
culture media and DMSO was used as a solvent. Standard sterilized 
filter paper disks (5 mm diameter) impregnated with a solution of 
the test compound in DMSO (1 mg/ml) was placed on agar plate 
seeded with the appropriate test organism in triplicates. The Petri 
plates were incubated at 37 °C for 24 h for bacterial strains and 48 h 
for fungi. After incubation, the plates were observed for the zone of 
inhibition. The Antimicrobial activities of synthesized compound 
were compared with Erythromycin and Gentamycin as standard. 
Each sample was tested in triplicate. 
Molecular docking studies 
Molecular docking studies were performed using accelrys discovery 
studio software program. The target protein enoyl acyl carrier 
protein reductase (InhA) from Mycobacterium tuberculosis (PDB ID-
2NSD) was downloaded from protein data bank and the active site 
was chosen. It was processed by the addition of hydrogen, assigning 
the bond order, identifying overlaps, creating zero-order bonds to 
metals and creating disulphide bonds. The co-factors, unwanted 
water molecules and chains were deleted. Then energy minimization 
was done followed by grid generation. The designed ligands were 
saved as mol format and were examined so as to generate the best 
pose by analyzing the binding interactions. The scoring functions 
and hydrogen bonds formed with the surrounding amino acids are 
used to predict their binding modes, their binding affinities and 
orientation of these compounds at the active site A of 2NSD. 
RESULTS AND DISCUSSION  
Aroylhydrazide derivatives were synthesized via condensation 
reaction by Schiff base route. All the products were immiscible in 
polar solvents and soluble with DMSO and DMF. The postulated 
structures of the newly synthesized compounds (table 1) were in 
good agreement with their FT-IR, 1H NMR and 13
(E)-N'-(2,4,5-triflorobenzylidene)benzohydrazide (B1) was derived 
from benzohydrazide and 2,4,5-triflorobenzaldehyde (1:1) Yield: 
96%. FT-IR: (ν in cm
C NMR spectral 
data.  
-1) 3409(NH), 3069(Ar-CH), 2848(Ali-CH), 
1645(CO). 1H NMR δ in ppm (400 MHz, DMSO-d6): 12.1(s, 1H, enolic 
NH), 8.7(s, 1H, CH=N), 7.9-7.5(m, 7H, Ar-H). 13C NMR δ in ppm (100 
MHz, DMSO-d6
(E)-4-chloro-N'-((2,4,5-triflorobenzylidene)benzohydrazide (P1) was 
derived from 4-chloro benzohydrazide and 2,4,5-trifloro-
benzaldehyde. (1:1) Yield: 97%. FT-IR: (ν in cm
) 163(CO), 138(C=N), 133, 132, 128, 127, 119, 113, 
107, 106(Ar-C).  
-1) 3475(NH), 
3059(Ar-CH), 2850(Ali-CH), 1616(CO).1H NMR δ in ppm (400 MHz, 
DMSO-d6): 11.9(s, 1H, enolic NH), 8.6(s, 1H, CH=N), 7.9(d, 2H, o-
ArCl), 7.8(s, 1H, o-ArF), 7.7(s, 1H, m-ArF), 7.0(d, 2H, m-ArCl).13C 
NMR δ in ppm (100 MHz, DMSO-d6
(E)-4-methoxy-N’-((2,4,5-triflorobenzylidene)benzohydrazide (J1) 
was derived from 4-methoxy benzohydrazide and 2,4,5-
triflorobenzaldehyde (1:1) Yield: 98%. FT-IR: (ν in cm-1) 
3474(NH), 3059(Ar-CH), 2849(Ali-CH), 1617(CO). 1H NMR δ in 
ppm (400 MHz, DMSO-d6): 11.9(s, 1H, enolic NH), 8.6(s, 1H, 
CH=N), 7.9(d, 2H, o-ArOMe), 7.8(s, 1H, o-ArF), 7.7(s, 1H, m-ArF), 
7.1(d, 2H, m-ArOMe). 13C NMR δ in ppm (100 MHz, DMSO-d6) 
162(CO), 157(C=N), 154, 152, 151, 148, 145, 137, 129, 119, 113, 
107, 106(Ar-C), 55(OMe). 
Antimicrobial activity 
) 162(CO), 157(C=N), 154, 152, 
148, 145, 144, 137, 129, 124, 119, 113, 107, 106(Ar-C). 
The antimicrobial activities of synthesized compounds were 
given in table 1. All the compounds show better activity against 
S. aureus and A. niger. At the same time, activity against E. coli 
was found to be less for all the three compounds. In short, P1 
shows comparatively greater anti-bacterial activity and J1 shows 
good anti-fungal activity. 
  
Table 1: Antimicrobial activities of aroylhydrazones 
Compound id Zone of inhibhition (mm) 
S. aureus E. coli A. niger 
B1 12±0.81 11±0.19 11±0.13 
J1 22±0.41 17±0.25 13±0.16 
P1 18±0.62 14±0.32 16±0.14 
Erythromycin 28±0.31 23±0.09 25±0.14 
Gentamycin 16±0.37 22±0.22 14±0.21 
 
While comparing the presence of substituents in the aromatic 
ring of hydrazides, the presence of electron donating group 
enhanced the antimicrobial activities whereas the presence of 
electron withdrawing group significantly reduced the activities 
[16]. 
Molecular docking 
In order to find a suitable inhibitor for Mycobacterium tuberculosis, 
InhA docking study was carried out. InhA catalyzes the reduction of 
long-chain trans-2-enoyl-ACP in the type II fatty acid biosynthesis 
pathway of M. tuberculosis
The types and number of interactions between the synthesized 
aroylhydrazones and Mycobacterium tuberculosis InhA were 
shown in fig. 1-4. The more negative value of Cdocker interaction 
energy indicates the good binding potential or the more anti-
tuberculosis activity against Mycobacterium tuberculosis InhA 
protein. 
. Inhibition of InhA disrupts the 
biosynthesis of the mycolic acids that are central constituents of 
the mycobacterial cell wall. The docking scores were shown in 
table 2.  
Manjula et al. 




Fig. 1: Binding configuration of B1 with 2NSD 
 
 
Fig. 2: Binding configuration of P1 with 2NSD 
 
 
Fig. 3: Binding configuration of J1 with 2NSD 
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Fig. 4: Binding configuration of isoniazid with 2NSD 
 
Table 2: Statistical docking results of the aroylhydrazones [ADS version 2.5 software] 
Compound id Potential 
energy 












B1 13.15033 3.12177 1.32932 43.22383 0.09303 -22.9303 -37.3152 
P1 11.98248 3.60418 -2.98297 41.26503 0.09358 -27.9953 -40.7347 
J1 14.03885 2.92098 1.03532 43.24664 0.08363 -29.6707 -44.3367 
Isoniazid 
(standard) 
-6.67385 1.78410 -11.80107 42.51513 0.07183 -22.1896 -27.3771 
 
Table 3: Molecular interactions of aroylhydrazones with active site residues of 2NSD 
Compound id Interaction details 
Type Number Residues involved 
B1 Electrostatic 2 (1) Between–C=O-of benzo hydrazide and of amino acid residue LYS A: 165 
(2) Between fluorine of aldehyde and of amino acid residue ILE A: 21 
J1 Electrostatic 1 Between fluorine of aldehyde and NAD 300 of amino acid residue 
P1 Electrostatic 1 Between–C=O-of benzo hydrazide and NAD 300 of amino acid residue 
Isoniazid Electrostatic 2 (1) Between–C=O-of benzo hydrazide and and of amino acid residue LYS A: 165 
(2) Between hydrogen of benzohdrazide and LYS A: 165 of amino acid residue  
Van der Walls  1 Between hydrogen of benzohydrazide and of amino acid residue ASP: 148 
From the results of docking, it was found that CDocker score of compound B1 was more negative. This implied that B1 needed only less energy to 
bind with the active site of the pathogen. At the same time, it made two numbers of electrostatic interactions with amino acid residue LYS A: 165 
which was comparable with that of standard drug isoniazid. Therefore compound B1may be suitable to overcome the drug resistance of enoyl acyl 
carrier protein reductase (InhA) from Mycobacterium tuberculosis. 
 
CONCLUSION 
Novel aroylhydrazones were synthesised using the simple and 
convenient method. The antimicrobial activities of the synthesized 
compounds screened against gram positive S. aureus and gram-
negative E. coli bacterial and A. niger fungi strains reveals that all the 
compounds may acts as a potential antimicrobial activity. To expand 
the knowledge about anti-tuberculosis activity against 
Mycobacterium tuberculosis InhA, molecular docking study was 
performed. Compound B1 shows good binding ability with two 
electrostatic interactions, which is comparable with that of isoiazid, 
standard drug. Therefore, B1 was found to possess the good 
inhibitory capability and it may be suitable to overcome the drug 
resistance of Mycobacterium tuberculosis InhA protein. 
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